Sustained Long-Term Benefit of Gene Therapy for SMA ...Middle East

Medscape - News
A single infusion of onasemnogene abeparvovec (Zolgensma) provides sustained benefits for up to 6 years in children with SMA, with no new safety signals. Medscape Medical News

Hence then, the article about sustained long term benefit of gene therapy for sma was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sustained Long-Term Benefit of Gene Therapy for SMA )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News